[1]COOLEY C, DENDLE J, WOLF B, et al.Consensus guidelines for diagnosis, prophylaxis and management of pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies[J].Intern Med J, 2014, 44 (12b) :1350-1363.
|
[2]GILROY S, BENNETT N.Pneumocystis pneumonia[J].Semin Respir Crit Care Med, 2011, 32 (6) :775-782.
|
[3]BRAKEMEIER S, PFAU A, ZUKUNFT B, et al.Prophylaxis and treatment of pneumocystis jirovecii pneumonia after solid organ transplantation[J].Pharmacol Res, 2018, 134 (8) :61-67.
|
[4]MARTIN SI, FISHMAN JA.AST Infectious Diseases Community of Practice.Pneumocystis pneumonia in solid organ transplantation[J].Am J Transplant, 2013, 3 (4) :272-279.
|
[5]TU GW, JU MJ, XU M, et al.Combination of caspofungin and low-dose trimethoprim/sulfamethoxazole for the treatment of severe Pneumocystis jirovecii pneumonia in renal transplant recipients[J].Nephrology (Carlton) , 2013, 18 (11) :736-742.
|
[6]ZHANG DL, ZANG H, GAO YJ, et al.Clinical features of pure red cell aplasia associated with human parvovirus B19 infection after liver transplantation[J].J Clin Hepatol, 2017, 33 (1) :146-149. (in Chinese) 张达利, 臧红, 高银杰, 等.肝移植术后发生人细小病毒B19相关纯红细胞再生障碍性贫血的临床特点分析[J].临床肝胆病杂志, 2017, 33 (1) :146-149.
|